CAPS (Central Admixture Pharmacy Service Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • CAPS (Central Admixture Pharmacy Service's estimated annual revenue is currently $81.8M per year.(i)
  • CAPS (Central Admixture Pharmacy Service's estimated revenue per employee is $201,000

Employee Data

  • CAPS (Central Admixture Pharmacy Service has 407 Employees.(i)
  • CAPS (Central Admixture Pharmacy Service grew their employee count by 10% last year.

CAPS (Central Admixture Pharmacy Service's People

NameTitleEmail/Phone
1
Sr. Systems AdministratorReveal Email/Phone
2
PharmacistReveal Email/Phone
3
Director PharmacyReveal Email/Phone
4
Project PharmacistReveal Email/Phone
5
Pharmacy/ Warehouse ClerkReveal Email/Phone
6
Staff PharmacistReveal Email/Phone
7
Engineering Facilities ManagerReveal Email/Phone
8
Manager CAPS Technical TrainingReveal Email/Phone
9
Director PharmacyReveal Email/Phone
10
PharmacistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

CAPS®, the nation's largest network of outsourcing admixture pharmacies, has been delivering high-quality, same-day, admixture services and solutions to hospitals and outpatient facilities for more than 28 years. Along with the nation?s largest 503A network, CAPS offers industry-leading batch compounding on a national scale through three 503B-registered outsourcing facilities. With experience, capacity, and a passion for safety, CAPS is your 503B solution. CAPS is part of the B. Braun Group of Companies in the U.S.

keywords:N/A

N/A

Total Funding

407

Number of Employees

$81.8M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$55.4M4435%N/A
#2
$127.4M4977%N/A
#3
$168.1M4986%N/A
#4
$187.7M556-2%N/A
#5
$107.5M593-18%N/A